![]() |
市场调查报告书
商品编码
1636691
2030 年动物生长促进剂市场预测:按产品类型、形式、牲畜、成分、应用和地区进行的全球分析Animal Growth Promoter Market Forecasts to 2030 - Global Analysis By Product Type (Antibiotics, Hormones, Enzymes, Probiotics, Prebiotics and Other Product Types), Form, Livestock, Source, Application and By Geography |
根据 Stratistics MRC 的数据,全球动物生长促进剂市场预计在 2024 年达到 196 亿美元,到 2030 年将达到 290 亿美元,预测期内的复合年增长率为 6.7%。
动物生长促进剂(AGP)是添加到动物饲料中以促进生长、提高饲料效率和预防疾病的物质。 AGP 包括抗生素、荷尔蒙和其他刺激生理过程的添加剂,帮助牲畜更快增加体重并改善其整体健康状况。 AGP 通常用于农业以提高生产力,但其使用引发了人们对抗生素抗药性和对人类健康的潜在影响的担忧,导致许多国家加强了监管。
根据联合国粮食及农业组织(FAO)的数据,2017年美国牲畜数量为9,370万头。
肉类和肉类需求不断增加
全球对肉类和肉类的需求不断增长,大大推动了市场的成长。随着消费者偏好转向富含蛋白质的饮食,对高效畜牧业生产的需求日益增加。牲畜生长促进剂越来越多地被用在提高生长速度、改善饲料效率和确保肉类的高品质。这种需求在新兴市场尤其明显,这些市场的可支配收入不断增加和都市化刺激了肉类消费,进一步推动了市场扩张。
安全问题
对动物生长促进剂安全性的担忧给市场带来了重大挑战。生长激素、抗生素和其他添加剂的使用引发了人们对它们可能在肉类中残留的担忧,对消费者的健康构成风险。这些担忧导致监管机构加强审查。此外,舆论反弹可能会损害品牌声誉,并引发向天然和有机替代品的转变,对传统生长促进剂的使用和市场成长构成挑战。
加强抗生素使用的监管
抗生素使用的严格监管正在重塑该行业。出于对抗生素抗药性和食品安全的担忧,世界各国政府都在实施限制抗生素使用的指导方针。这导致人们转向使用益生菌、酵素和植物来源添加剂等替代生长促进剂。因此,市场正在看到更安全的非抗生素解决方案的创新,生产商正在专注于永续的实践,以满足消费者对更健康、无抗生素肉类产品的需求。
高成本
动物生长促进剂成本高是市场面临的一大挑战。某些添加剂,如荷尔蒙、抗生素和益生菌,价格昂贵,会增加畜牧农民的生产成本并降低盈利。小型畜牧农户将难以购买这些产品,而大公司可能会垄断这些产品,从而导致市场集中。此外,投入成本上升可能导致肉类价上涨,影响消费需求。这些经济压力可能会阻碍市场成长。
新冠肺炎疫情为市场带来了重大影响,扰乱了供应链并降低了生产能力。封锁和劳动力短缺影响了生长促进剂关键成分的供应,从而导致延误和价格上涨。这场疫情凸显了粮食安全的重要性,也增加了人们对高效率畜牧养殖实务的兴趣。这导致了人们转向更永续且更具成本效益的生长促进剂。
抗生素市场预计将成为预测期内最大的市场
预计预测期内抗生素领域将占据最大的市场占有率。这些抗生素可以帮助动物更有效地增加体重,并减少感染疾病的机会。然而,人们对抗生素抗药性及其对人体的潜在影响的担忧日益加剧,导致一些国家出台了更严格的规定。这种转变正在塑造市场的未来,鼓励采用益生菌、酵素和草药补充剂等替代的促进生长的策略。
预计饲料添加剂领域在预测期内将出现最高复合年增长率
预计预测期内饲料添加剂部分将以最高的复合年增长率成长。这些添加剂包括维生素、矿物质、酵素、益生菌和有机酸,可提高饲料效率、支持消化并增强免疫功能。作为抗生素的替代品,饲料添加剂因其在促进永续和健康的畜牧业生产中的作用而越来越受欢迎。人们对抗生素抗药性的担忧日益加剧,推动了对天然和安全饲料添加剂的需求,预计这将影响市场成长。
预计预测期内北美地区将占据最大的市场占有率。重点提高牲畜生产率和饲料效率,广泛使用抗生素、饲料添加剂和其他促进生长技术。然而,随着监管机构对抗生素使用的审查力度加大,以及消费者对有机和无抗生素产品的偏好日益增加,市场正在重塑。该地区对替代性的、永续的成长促进解决方案的兴趣也日益浓厚。
预计亚太地区将在预测期内实现最高成长率。亚太地区收入的提高和都市化推动了肉类和乳製品需求的激增,进一步增加了对动物生长促进剂的需求,以满足生产需求。此外,集约化农业实践和先进技术的采用也增加了对确保更快、更有效率生产的生长促进剂的需求。
According to Stratistics MRC, the Global Animal Growth Promoter Market is accounted for $19.6 billion in 2024 and is expected to reach $29.0 billion by 2030 growing at a CAGR of 6.7% during the forecast period. An Animal Growth Promoter (AGP) is a substance added to animal feed to enhance growth, improve feed efficiency, or prevent diseases. AGPs include antibiotics, hormones, and other additives that stimulate physiological processes, leading to faster weight gain and better overall health in livestock. While they are commonly used in the farming industry to boost productivity, their use has raised concerns about antibiotic resistance and potential impacts on human health, leading to increasing regulations in many countries.
According to the Food and Agriculture Organization (FAO) of the United Nations, the U.S. had 93.7 million cattle in 2017.
Rising demand for meat and meat products
The rising demand for meat and meat products globally is significantly driving the growth of the market. As consumer preferences shift toward protein-rich diets, the need for efficient livestock production increases. Animal growth promoters are increasingly used to enhance growth rates, improve feed efficiency, and ensure the availability of high-quality meat. This demand is particularly evident in developing regions, where increasing disposable incomes and urbanization are fueling meat consumption, further boosting market expansion.
Concerns about the safety
Concerns about the safety of animal growth promoters have raised significant issues in the market. The use of growth hormones, antibiotics, and other additives has sparked fears regarding potential residue in meat products, posing health risks to consumers. These concerns are leading to increased scrutiny from regulatory bodies. Additionally, public backlash against unsafe practices may harm brand reputation, causing a shift toward natural, organic alternatives, which challenges traditional growth promoter usage and market growth.
Stricter regulations on the use of antibiotics
Stricter regulations on the use of antibiotics in the market are reshaping the industry. Governments worldwide are enforcing guidelines to limit antibiotic usage due to concerns over antimicrobial resistance and food safety. This has led to a shift towards alternative growth promoters such as probiotics, enzymes, and plant-based additives. As a result, the market is witnessing innovation in safer, non-antibiotic solutions, with producers focusing on sustainable practices to meet consumer demand for healthier, antibiotic-free meat products.
High costs
High costs of animal growth promoters are a significant challenge in the market. The expensive nature of certain additives, such as hormones, antibiotics, and probiotics, increases production costs for livestock farmers, potentially reducing their profitability. Smaller-scale producers may struggle to afford these products, leading to market concentration as larger players dominate. Additionally, rising input costs could lead to higher meat prices, affecting consumer demand. These financial pressures can hinder market growth.
The COVID-19 pandemic significantly impacted the market, disrupting supply chains and reducing production capacity. Lockdowns and labor shortages affected the availability of key ingredients for growth promoters, leading to delays and price hikes. The pandemic highlighted the importance of food security, prompting increased interest in efficient livestock farming practices. This led to a shift towards more sustainable and cost-effective growth promoter solutions.
The antibiotics segment is expected to be the largest during the forecast period
The antibiotics segment is anticipated to account for the largest market share during the projection period. These antibiotics help animals reach market weight more efficiently and reduce the likelihood of infections. However, growing concerns about antibiotic resistance and its potential effects on human health have led to stricter regulations in several countries. This shift is encouraging the adoption of alternative growth-promoting strategies, such as probiotics, enzymes, and herbal supplements, shaping the future of the market.
The feed additives segment is expected to have the highest CAGR during the forecast period
The feed additives segment is expected to have the highest CAGR during the extrapolated period. These additives include vitamins, minerals, enzymes, probiotics, and organic acids that improve feed efficiency, support digestion, and boost immune function. As an alternative to antibiotics, feed additives are gaining popularity due to their role in promoting sustainable and healthier animal production. With increasing concerns about antibiotic resistance, demand for natural and safe feed additives is expected to rise, influencing the market's growth.
North America region is anticipated to account for the largest market share during the forecast period. With a strong focus on improving livestock productivity and feed efficiency, antibiotics, feed additives, and other growth-promoting technologies are widely used. However, increasing regulatory scrutiny on antibiotic use, along with rising consumer preference for organic and antibiotic-free products, is reshaping the market. The region is also witnessing growing interest in sustainable and alternative growth promotion solutions.
Asia Pacific is expected to register the highest growth rate over the forecast period. Increased incomes and urbanization in Asia Pacific have contributed to a surge in the demand for meat and dairy products, further driving the need for animal growth promoters to meet production requirements. Additionally, the adoption of intensive farming methods and advanced technologies has contributed to the demand for growth promoters to ensure faster and more efficient production.
Key players in the market
Some of the key players in Animal Growth Promoter market include Zoetis, Bayer Animal Health, Merck Animal Health, Boehringer Ingelheim Animal Health, Cargill, Inc., BASF SE, ADM Animal Nutrition, Nutreco N.V., Evonik Industries AG, Alltech Inc., DSM Nutritional Products, Lonza Group, BioZyme Inc., Novozymes and American Vanguard Corporation.
In February 2024, Blacksmith Medicines, Inc., a global biopharmaceutical company, and Zoetis, a global animal health company, announced a collaboration, to discover and develop novel antibiotics for animal health
In July 2021, ADM has announced the launch of a customized antibiotic reduction program developed by Wisium, its premix and nutrition services business. The new program centralizes Wisium's demedication solutions across all species, such as poultry, cattle and swine, offering a holistic approach.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.